Apyx Medical Net Income
| APYX Stock | USD 3.92 0.08 2.08% |
As of the 19th of February, Apyx Medical shows the Mean Deviation of 2.62, risk adjusted performance of (0.01), and Standard Deviation of 3.71. Apyx Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Apyx Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.4802 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -21.2 M | -20.1 M | |
| Net Loss | -20.9 M | -19.8 M | |
| Net Loss | -21.2 M | -20.1 M | |
| Net Loss | (0.76) | (0.72) | |
| Net Income Per E B T | 1.16 | 1.01 |
Apyx | Net Income | Build AI portfolio with Apyx Stock |
The evolution of Net Income for Apyx Medical provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Apyx Medical compares to historical norms and industry peers.
Latest Apyx Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Apyx Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Apyx Medical financial statement analysis. It represents the amount of money remaining after all of Apyx Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Apyx Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (23.56 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Apyx Net Income Regression Statistics
| Arithmetic Mean | (7,337,274) | |
| Geometric Mean | 6,583,143 | |
| Coefficient Of Variation | (277.15) | |
| Mean Deviation | 12,300,952 | |
| Median | (11,896,000) | |
| Standard Deviation | 20,335,455 | |
| Sample Variance | 413.5T | |
| Range | 87.5M | |
| R-Value | (0.37) | |
| Mean Square Error | 380.7T | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | (1,489,544) | |
| Total Sum of Squares | 6616.5T |
Apyx Net Income History
Other Fundumenentals of Apyx Medical
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Apyx Medical Net Income component correlations
Apyx Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Apyx Medical is extremely important. It helps to project a fair market value of Apyx Stock properly, considering its historical fundamentals such as Net Income. Since Apyx Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Apyx Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Apyx Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apyx Medical. If investors know Apyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Apyx Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.36) | Revenue Per Share | Quarterly Revenue Growth 0.121 | Return On Assets | Return On Equity |
The market value of Apyx Medical is measured differently than its book value, which is the value of Apyx that is recorded on the company's balance sheet. Investors also form their own opinion of Apyx Medical's value that differs from its market value or its book value, called intrinsic value, which is Apyx Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apyx Medical's market value can be influenced by many factors that don't directly affect Apyx Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apyx Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apyx Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apyx Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Apyx Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Apyx Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Apyx Medical.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Apyx Medical on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Apyx Medical or generate 0.0% return on investment in Apyx Medical over 90 days. Apyx Medical is related to or competes with Quipt Home, Rapid Micro, Avita Medical, Lucid Diagnostics, Xtant Medical, Vivani Medical, and InspireMD. Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmeti... More
Apyx Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Apyx Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Apyx Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 24.47 | |||
| Value At Risk | (5.46) | |||
| Potential Upside | 5.15 |
Apyx Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apyx Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Apyx Medical's standard deviation. In reality, there are many statistical measures that can use Apyx Medical historical prices to predict the future Apyx Medical's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Apyx Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Apyx Medical February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.62 | |||
| Coefficient Of Variation | (4,400) | |||
| Standard Deviation | 3.71 | |||
| Variance | 13.76 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 24.47 | |||
| Value At Risk | (5.46) | |||
| Potential Upside | 5.15 | |||
| Skewness | 1.07 | |||
| Kurtosis | 3.87 |
Apyx Medical Backtested Returns
At this stage we consider Apyx Stock to be moderately volatile. Apyx Medical secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Apyx Medical, which you can use to evaluate the volatility of the firm. Please confirm Apyx Medical's Mean Deviation of 2.62, risk adjusted performance of (0.01), and Standard Deviation of 3.71 to double-check if the risk estimate we provide is consistent with the expected return of 0.0302%. The firm shows a Beta (market volatility) of 0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Apyx Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Apyx Medical is expected to be smaller as well. Apyx Medical right now shows a risk of 3.67%. Please confirm Apyx Medical value at risk and rate of daily change , to decide if Apyx Medical will be following its price patterns.
Auto-correlation | -0.43 |
Modest reverse predictability
Apyx Medical has modest reverse predictability. Overlapping area represents the amount of predictability between Apyx Medical time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Apyx Medical price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Apyx Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.43 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Apyx Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Apyx Medical reported net income of (23.56 Million). This is 106.9% lower than that of the Health Care Equipment & Supplies sector and 109.89% lower than that of the Health Care industry. The net income for all United States stocks is 104.13% higher than that of the company.
Apyx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apyx Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apyx Medical could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics of similar companies.Apyx Medical is currently under evaluation in net income category among its peers.
Apyx Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Apyx Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Apyx Medical's managers, analysts, and investors.Environmental | Governance | Social |
Apyx Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Apyx Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Apyx Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Apyx Medical's value.| Shares | Perkins Capital Management Inc | 2025-06-30 | 227 K | Kingsview Wealth Management, Llc | 2025-06-30 | 191.6 K | Renaissance Technologies Corp | 2025-06-30 | 181.4 K | Perceptive Advisors Llc | 2025-06-30 | 150 K | Northern Trust Corp | 2025-06-30 | 119.1 K | State Street Corp | 2025-06-30 | 109.3 K | Caption Management, Llc | 2025-06-30 | 107.7 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 75.3 K | Bridgeway Capital Management, Llc | 2025-06-30 | 61.6 K | Nantahala Capital Management, Llc | 2025-06-30 | 3.3 M | Archon Capital Management Llc | 2025-06-30 | 3.3 M |
Apyx Fundamentals
| Return On Equity | -1.68 | ||||
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 166.71 M | ||||
| Shares Outstanding | 41.03 M | ||||
| Shares Owned By Insiders | 13.41 % | ||||
| Shares Owned By Institutions | 44.62 % | ||||
| Number Of Shares Shorted | 127.03 K | ||||
| Price To Earning | 4.04 X | ||||
| Price To Book | 26.10 X | ||||
| Price To Sales | 3.29 X | ||||
| Revenue | 48.1 M | ||||
| Gross Profit | 30.01 M | ||||
| EBITDA | (16.8 M) | ||||
| Net Income | (23.56 M) | ||||
| Cash And Equivalents | 20.06 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 38.76 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 4.45 X | ||||
| Book Value Per Share | 0.15 X | ||||
| Cash Flow From Operations | (18.05 M) | ||||
| Short Ratio | 1.01 X | ||||
| Earnings Per Share | (0.36) X | ||||
| Price To Earnings To Growth | (0.58) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 220 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 157.55 M | ||||
| Total Asset | 64.84 M | ||||
| Retained Earnings | (77.91 M) | ||||
| Working Capital | 45.72 M | ||||
| Current Asset | 10.01 M | ||||
| Current Liabilities | 2.45 M | ||||
| Net Asset | 64.84 M |
About Apyx Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.